‘Global Allegiance’ of Inspectorates Emerging
By
Bowman Cox / Email the Author / “The Gold Sheet” November 2010, Vol. 44, No. 11
Word Count: 4333 / Article # 08101122001
Executive Summary
Drug regulatory agencies around the world are beginning to coordinate their inspection processes, which could reduce global drug manufacturers’ burden of hosting multiple GMP inspections.Some are piloting joint inspections, with a pilot for active pharmaceutical ingredient manufacturers concluding next month, and a second for drug product manufacturers under way.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.